http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2634094-T3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_76ee4334a1024d7d74e0b2b87181d6a0 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2077 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-685 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2866 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2095 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2077 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-685 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P33-02 |
| filingDate | 2011-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3596cb07697b464b168c463165293c82 |
| publicationDate | 2017-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2634094-T3 |
| titleOfInvention | Solid dosage forms of oleyl phospholine |
| abstract | Method for the preparation of a solid dosage form of oleyl phosphocholine for oral administration, characterized in that it comprises: a) adding to a dry mixture comprising one or more pharmaceutically acceptable diluents / fillers, disintegrants and / or binders, water comprising 6 to 25% by weight of oleyl phosphocholine; b) drying and sieving the mixture obtained in step (a); c) add one or more disintegrants and / or lubricants to the mixture obtained in step (b); d) mixing the mixture obtained in step (c); e) preparing an oral dosage form of the mixture of step (d), preferably by compression molding; wherein said solid dosage form provides a friability of less than 1% by weight, preferably less than 0.5% by weight, of the solid dosage form as determined in accordance with the European Pharmacopoeia 2.9.7 standard friability test and / or said solid dosage form provides a disintegration of less than 15 minutes, preferably less than 10 minutes, as determined by the standard European Pharmacopoeia 2.9.1 disintegration test. |
| priorityDate | 2010-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 143.